BioSpace News Archive

Lykan Bioscience, a contract Manufacturing Services Organization™ (MSO) and provider of the first true end-to-end solution for the manufacture of cell-based therapies, welcomes Keith McCormick as Chief Financial Officer.

Cortexyme, Inc., a clinical-stage biopharmaceutical company focused on Alzheimer’s and other degenerative diseases, received a letter from the U.S. Food and Drug Administration stating that a partial clinical hold has been placed on atuzaginstat impacting the open-label extension phase of the company’s ongoing Phase 2/3 study, the GAIN Trial.

Early demonstration of favorable LUMEVOQ® safety profile in human subjects subsequently confirmed in later trials

Lysogene, a phase 3 gene therapy platform company targeting central nervous system diseases, reports biomarker data from the ongoing AAVance clinical trial with LYS-SAF302 for the treatment of MPS IIIA presented at the WORLDSymposium™ 2021 by Dr. Michaël Hocquemiller, Head of Non-Clinical Development, during the Late-Breaking Science session held on Friday, February 12, 2021.

Wound dressing is used to provide optimum conditions for the healing of the wound. It protects the wound from further pathogenic microorganisms invasions and trauma.

There has been augmented focus on personalized medicines and drug discovery utilizing in vitro methods.

Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of synthetic biology to medicine, today announced that Aoife Brennan , M.B. Ch.B., Synlogic’s President and Chief Executive Officer, and other members of the executive team will present at the following virtual banking and industry conference

Targovax ASA, a clinical stage immune-oncology company developing immune activators to target hard-to-treat solid tumors, announces that its lead clinical candidate ONCOS-102 has received Fast-Track designation in malignant pleural mesothelioma from the US FDA.

Elekta invites analysts and investors to a presentation of the third quarter 2020/21 at 10:00 a.m. CET on February 25.

Patient access to quality health and medical care is of the seminal pillars of the healthcare systems around the world.